Literature DB >> 23466462

Incomplete kawasaki disease in an elderly man.

Gilles Safa1, Clémence Saillard, Laure Darrieux.   

Abstract

Kawasaki disease (KD) is a systemic vasculitis of unknown etiology, affecting predominantly young children. Here, we describe an unusual case of a 75-year-old man with several unique features of incomplete KD. Healthcare professionals should therefore be aware of the importance of considering KD at any age, even among elderly individuals. This case also highlights the usefulness of the algorithm proposed for children to diagnose incomplete KD in adults.

Entities:  

Keywords:  Adult; Diagnosis; Incomplete Kawasaki disease

Year:  2013        PMID: 23466462      PMCID: PMC3573789          DOI: 10.1159/000346567

Source DB:  PubMed          Journal:  Case Rep Dermatol        ISSN: 1662-6567


Introduction

Kawasaki disease (KD) is an acute systemic vasculitis of unknown cause that occurs primarily in children and rarely in adults [1]. In the absence of specific laboratory tests, the diagnosis of KD can be challenging, especially in adults. We report an unusual case of an elderly man with several unique features of incomplete KD.

Case Presentation

A 75-year-old white man was admitted to our hospital for a 3-week history of fever and poor general condition. His past medical history included hypertension, hyperlipidemia, myocardial infarction, and a coronary artery bypass graft surgery 2 years ago. The patient denied any recent changes in medications. On admission, the patient was febrile (39°C), and physical examination revealed bilateral nonpurulent conjunctivitis, red and cracked lips (fig. 1), and slightly edematous erythema with desquamation of the hands and feet (fig. 2a, b). Cervical, axillary and inguinal adenopathy was absent. There were no other abnormal physical examination findings.
Fig. 1

Cracked, red lips.

Fig. 2

a, b Erythema with periungual desquamation of the fingers and toes.

Laboratory tests revealed anemia (hemoglobin 8.5 g/dl), hypoalbuminemia (2.6 g/dl), elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) (83 mm/h and 100.3 mg/l, respectively), elevated alanine aminotransferase (56 IU/l; normal <40), and sterile leukocyturia (30 cells/µl). Blood and urine cultures were negative. Serological assays for human immunodeficiency virus, hepatotropic viruses, Epstein-Barr virus, cytomegalovirus, and antinuclear antibodies were negative. Chest radiography and echocardiography were normal. Based on these findings, a diagnosis of incomplete KD was strongly suspected. The patient was subsequently treated with an intravenous immunoglobulin infusion (1 g/kg for 2 days) and high-dose aspirin (3 g/day). The fever remitted within 3 days, and within 1 week, the laboratory abnormalities returned to normal and mucocutaneous lesions improved dramatically. Low-dose aspirin, which the patient had taken since his bypass surgery, was then restarted. The patient was discharged and instructed to follow up with his referring cardiologist.

Discussion

KD is defined as the presence of a fever for ≥5 days and ≥4 of the 5 major clinical features: conjunctivitis, oral mucosal changes, polymorphous rash, palmoplantar erythema with desquamation, and cervical lymphadenopathy [1]. Incomplete KD refers to patients who do not fulfill the classic criteria of ≥4 of the 5 findings and in whom alternative diagnoses have been ruled out [2]. In adults, the main differential diagnoses are drug hypersensitivity reaction and toxic shock syndrome [3]. The higher prevalence of coronary artery lesions in patients with incomplete KD reflects difficulties in diagnosis and delays in treatment [4]. Although adults are less frequently affected by coronary aneurysms compared with children (5 vs. 20%, respectively), establishing the diagnosis of incomplete KD and initiating treatment is essential [3]. In 2004, a multidisciplinary committee of experts proposed an algorithm to diagnose incomplete KD in children [5]. For pediatric patients with a fever for ≥5 days and <4 classical criteria of KD, laboratory tests, including CRP and ESR, should be obtained. In patients with elevated CRP (≥30 mg/l) and/or ESR (≥40 mm/h) levels who fulfill ≥3 supplemental laboratory criteria [including albumin ≤3.0 g/dl, anemia, elevation of alanine aminotransferase, ≥450,000/mm3 platelets after 7 days, white blood count ≥15,000/mm3, and sterile pyuria (≥10 cells/high-power field)], intravenous immunoglobulin and aspirin should be instituted and echocardiography should be performed. Our case emphasizes the importance of considering KD at any age, even among elderly individuals. This case also highlights the usefulness of the algorithm proposed for children to diagnose incomplete KD in adults.

Disclosure Statement

The authors have no conflicts of interest to disclose.
  5 in total

Review 1.  Kawasaki disease in adults: report of 10 cases.

Authors:  Emeline Gomard-Mennesson; Cédric Landron; Claire Dauphin; Olivier Epaulard; Clemence Petit; Lisa Green; Pascal Roblot; Jean-René Lusson; Christiane Broussolle; Pascal Sève
Journal:  Medicine (Baltimore)       Date:  2010-05       Impact factor: 1.889

2.  Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan.

Authors:  Daisuke Sudo; Yoshiro Monobe; Mayumi Yashiro; Makiko Naka Mieno; Ritei Uehara; Keiji Tsuchiya; Tomoyoshi Sonobe; Yosikazu Nakamura
Journal:  Eur J Pediatr       Date:  2011-12-10       Impact factor: 3.183

3.  The treatment of Kawasaki syndrome with intravenous gamma globulin.

Authors:  J W Newburger; M Takahashi; J C Burns; A S Beiser; K J Chung; C E Duffy; M P Glode; W H Mason; V Reddy; S P Sanders
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

4.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Circulation       Date:  2004-10-26       Impact factor: 29.690

Review 5.  Kawasaki syndrome.

Authors:  Jane C Burns; Mary P Glodé
Journal:  Lancet       Date:  2004 Aug 7-13       Impact factor: 79.321

  5 in total
  2 in total

Review 1.  Adult Kawasaki disease in a European patient: a case report and review of the literature.

Authors:  Theano Kontopoulou; Dimitrios Georgios Kontopoulos; Emmanouel Vaidakis; George P Mousoulis
Journal:  J Med Case Rep       Date:  2015-04-01

2.  Acute cholestasis as uncommon onset of Kawasaki disease: a case report.

Authors:  Massimo Gallerani; Marco Pala; Fabio Fabbian; Alfredo De Giorgi
Journal:  BMC Gastroenterol       Date:  2020-10-28       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.